Cutaneous uses of the antiproliferative drugs.
D000287:Administration, Topical; D000963:Antimetabolites / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D001380:Azauridine / Q000031:analogs & derivatives / Q000627:therapeutic use; D001761:Bleomycin / Q000627:therapeutic use; D056486:Chemical and Drug Induced Liver Injury / Q000209:etiology; D004791:Enzyme Inhibitors; D006801:Humans; D006918:Hydroxyurea / Q000627:therapeutic use; D007167:Immunotherapy; D008545:Melanoma / Q000188:drug therapy; D008727:Methotrexate / Q000627:therapeutic use; D008938:Mitosis / Q000187:drug effects; D009182:Mycosis Fungoides / Q000188:drug therapy; D009928:Organ Specificity; D011565:Psoriasis / Q000188:drug therapy; D012878:Skin Neoplasms / Q000188:drug therapy / Q000532:radiotherapy / Q000628:therapy
D000963:Antimetabolites; D004791:Enzyme Inhibitors; D001761:Bleomycin; D001380:Azauridine; D006918:Hydroxyurea; D008727:Methotrexate